Rebecca A. Enos

2.4k total citations · 1 hit paper
13 papers, 1.2k citations indexed

About

Rebecca A. Enos is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Cancer Research. According to data from OpenAlex, Rebecca A. Enos has authored 13 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 7 papers in Economics and Econometrics and 3 papers in Cancer Research. Recurrent topics in Rebecca A. Enos's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Ethics in Clinical Research (6 papers) and Cancer Genomics and Diagnostics (3 papers). Rebecca A. Enos is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Ethics in Clinical Research (6 papers) and Cancer Genomics and Diagnostics (3 papers). Rebecca A. Enos collaborates with scholars based in United States, United Kingdom and France. Rebecca A. Enos's co-authors include Jo Anne Zujewski, Sally Hunsberger, Clifford A. Hudis, J. W. Chapman, Kathleen I. Pritchard, Joseph A. Sparano, William E. Barlow, Robert J. Gray, Joseph P. Costantino and Richard D. Gelber and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Rebecca A. Enos

12 papers receiving 1.2k citations

Hit Papers

Proposal for Standardized Definitions for Efficacy End Po... 2007 2026 2013 2019 2007 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System
    2007 558 citations Clifford A. Hudis, William E. Barlow et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rebecca A. Enos United States 8 712 659 243 197 189 13 1.2k
Irma Fredriksson Sweden 22 805 1.1× 946 1.4× 263 1.1× 281 1.4× 221 1.2× 64 1.5k
Vani Parmar India 20 782 1.1× 847 1.3× 239 1.0× 112 0.6× 342 1.8× 106 1.5k
Olive Kearins United Kingdom 21 883 1.2× 898 1.4× 452 1.9× 94 0.5× 206 1.1× 56 1.7k
Javaid Iqbal Canada 15 782 1.1× 1.1k 1.6× 381 1.6× 286 1.5× 206 1.1× 23 1.8k
Andrei Y. Yakovlev United States 9 725 1.0× 1.6k 2.4× 202 0.8× 266 1.4× 297 1.6× 12 2.2k
Gustavo Werutsky Brazil 17 872 1.2× 682 1.0× 422 1.7× 116 0.6× 325 1.7× 89 1.5k
Linda de Munck Netherlands 22 947 1.3× 980 1.5× 470 1.9× 91 0.5× 213 1.1× 79 1.6k
Rebecca A. Ottesen United States 18 1.1k 1.5× 1.2k 1.8× 275 1.1× 108 0.5× 273 1.4× 33 1.8k
Henry G. Kaplan United States 22 396 0.6× 831 1.3× 337 1.4× 233 1.2× 325 1.7× 79 1.6k
Robert P. Gray United States 15 859 1.2× 718 1.1× 352 1.4× 197 1.0× 181 1.0× 26 1.3k

Countries citing papers authored by Rebecca A. Enos

Since Specialization
Citations

This map shows the geographic impact of Rebecca A. Enos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca A. Enos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca A. Enos more than expected).

Fields of papers citing papers by Rebecca A. Enos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca A. Enos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca A. Enos. The network helps show where Rebecca A. Enos may publish in the future.

Co-authorship network of co-authors of Rebecca A. Enos

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca A. Enos. A scholar is included among the top collaborators of Rebecca A. Enos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca A. Enos. Rebecca A. Enos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Shah, Nirali N., Percy Ivy, Rebecca A. Enos, et al.. (2020). Expanded access trial of tocilizumab in COVID19+hospitalized cancer patients. Clinical Cancer Research. 26(18). 1 indexed citations
2.
Levy, Elliot, Maria Isabel Fiel, Stanley R. Hamilton, et al.. (2020). State of the Art: Toward Improving Outcomes of Lung and Liver Tumor Biopsies in Clinical Trials—A Multidisciplinary Approach. Journal of Clinical Oncology. 38(14). 1633–1640. 10 indexed citations
3.
Makhlouf, Hala R., Mark A. Watson, Heather A. Lankes, et al.. (2019). Toward Improving Practices for Submission of Diagnostic Tissue Blocks for National Cancer Institute Clinical Trials. American Journal of Clinical Pathology. 153(2). 149–155. 6 indexed citations
4.
Germain, Diane St., Andrea Denicoff, Eileen Dimond, et al.. (2014). Use of the National Cancer Institute Community Cancer Centers Program Screening and Accrual Log to Address Cancer Clinical Trial Accrual. Journal of Oncology Practice. 10(2). e73–e80. 37 indexed citations
5.
Polley, Mei‐Yin C., Samuel Leung, Lisa M. McShane, et al.. (2013). An International Ki67 Reproducibility Study. JNCI Journal of the National Cancer Institute. 105(24). 1897–1906. 429 indexed citations
6.
Zaren, Howard A., Suresh Nair, Ronald S. Go, et al.. (2013). Early-Phase Clinical Trials In The Community: Results From the National Cancer Institute Community Cancer Centers Program Early-Phase Working Group Baseline Assessment. Journal of Oncology Practice. 9(2). e55–e61. 10 indexed citations
7.
8.
9.
Grubbs, Stephen S., Ronald S. Go, Maxwell Thompson, et al.. (2011). Early success in narrowing age, gender, and racial disparities in clinical trial accrual: Targeted screening efforts through the National Cancer Institute Community Cancer Centers Program (NCCCP).. Journal of Clinical Oncology. 29(15_suppl). 6110–6110. 1 indexed citations
10.
Leyland‐Jones, Brian, Christine B. Ambrosone, John M.S. Bartlett, et al.. (2008). Recommendations for Collection and Handling of Specimens From Group Breast Cancer Clinical Trials. Journal of Clinical Oncology. 26(34). 5638–5644. 55 indexed citations
11.
Hudis, Clifford A., William E. Barlow, Joseph P. Costantino, et al.. (2007). Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System. Journal of Clinical Oncology. 25(15). 2127–2132. 558 indexed citations breakdown →
12.
Fine, Richard Ν., Estella M. Alonso, Janet E. Fischel, et al.. (2004). Pediatric transplantation of the kidney, liver and heart: Summary report. Pediatric Transplantation. 8(1). 75–86. 33 indexed citations
13.
Conley, Barbara A., Rebecca A. Enos, & Bruce D. Cheson. (2002). Clinical trials referral resource. Targeted therapy in squamous cell cancers of the head and neck.. PubMed. 16(5). 621–2, 625. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irma Fredriksson Breakdown of academic impact, for papers by Vani Parmar Breakdown of academic impact, for papers by Olive Kearins Breakdown of academic impact, for papers by Javaid Iqbal Breakdown of academic impact, for papers by Andrei Y. Yakovlev Breakdown of academic impact, for papers by Gustavo Werutsky Breakdown of academic impact, for papers by Linda de Munck Breakdown of academic impact, for papers by Rebecca A. Ottesen Breakdown of academic impact, for papers by Henry G. Kaplan Breakdown of academic impact, for papers by Robert P. Gray
Rankless by CCL
2026